Be a Smart Investor

Thursday, October 1, 2020

Continued Stimulus Optimism May Generate Early Buying Interest

The major U.S. index futures are pointing to a higher open on Thursday, with stocks likely to add to the gains posted in the previous session.

from RTT - Market Analysis https://ift.tt/3ikM4g7
via IFTTT

Conagra Brands Guides Q2 Adjusted EPS In Line With View; Boosts Dividend 29% - Quick Facts

While reporting financial results for the first quarter of fiscal 2021 on Thursday, Conagra Brands, Inc. (CAG) provided only its adjusted earnings and organic net sales growth guidance for the second quarter of fiscal 2021.

from RTT - Earnings https://ift.tt/3n8pFGI
via IFTTT

Solid Biosciences: FDA Lifts Clinical Hold On IGNITE DMD Clinical Trial

Solid Biosciences Inc. (SLDB), said Thursday that the U.S. Food and Drug Administration or FDA has lifted the clinical hold placed on the company's IGNITE DMD Phase I/II clinical trial.

from RTT - Biotech https://ift.tt/36p25j0
via IFTTT

PepsiCo Q3 Results Top Estimates; Reinstates Core EPS Outlook Above Estimates

Snack and beverage giant PepsiCo Inc. (PEP) on Thursday reported a 16 percent decline in net income for the third quarter, reflecting revenue growth on continued strength in its global snacks and food business and improvement in its global beverage business. Both core earnings per share and net revenues for the quarter beat analysts' estimates.

from RTT - Earnings https://ift.tt/3jqmSXa
via IFTTT

Pfizer's Gene Therapy Candidate For Duchenne Muscular Dystrophy Receives Fast Track designation

Pfizer Inc. (PFE) said the company's investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (DMD) received Fast Track designation from the FDA. The designation was granted based on data from the phase 1b study that indicated that the intravenous administration of PF-06939926 was well-tolerated during the infusion period and dystrophin expression levels were sustained over a 12-month period.

from RTT - Biotech https://ift.tt/3cMGP7L
via IFTTT

Pre-market Movers In Healthcare Sector: AMAG, PRPH, GENE, ZSAN, SELB.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3l0nO4I
via IFTTT

SELB Down But Not Out, PFE Takes 9.9% Stake In CStone, ZSAN Plunges, AMAG On The Block?

Today's Daily Dose brings you news about AMAG reportedly in talks with Covis Pharma about being acquired, Iterum's progress with Sulopenem, Pfizer's stake in CStone, Selecta's Gout trial results, and FDA notification to Zosano over migraine treatment Qtrypta.

from RTT - Biotech https://ift.tt/3jlMCnj
via IFTTT